Cross Research S.A.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Arzo Switzerland (1996)

Organization Overview

First Clinical Trial
2006
NCT01280175
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CROSS Research, Arzo, Ticino, Switzerland | Cross Research SA | Cross Research S.A. | CROSS Research SA | CROSS-Research SA | CROSS Research S.A., I Unit, | CROSS Research S.A., Phase I Clinical Unit, Arzo, Switzerland | Cross Research S.A. Phase I Unit | CROSS Research S.A. Phase I Unit | CROSS Research S.A., Phase I Unit | CROSS Research SA, Phase I Unit, Via FA Giorgioli 12, 6864 Arzo Switzerland | CROSS Research S.A., Phase I Unit, Via F.A. Giorgioli 14 CH-6864 Arzo, Switzerland | Cross S.A.